Reliq Health Technologies Announces Appointment of Mr. Anthony de Werth to Advisory Board

Reliq Health Technologies > Blog Full Left Sidebar > Press Releases > Reliq Health Technologies Announces Appointment of Mr. Anthony de Werth to Advisory Board

VANCOUVER, BC, December 19, 2017 / – Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, is pleased to announce that Mr. Anthony (Tony) de Werth has joined its Advisory Board.

“We are thrilled to have Mr. de Werth join our Advisory Board,” said Dr. Lisa Crossley, CEO of Reliq Health.  “His Capital Markets expertise and experience guiding fast-growing companies like hyperWALLET to large scale success will be invaluable to Reliq Health going forward.”

Mr. de Werth’s career in the Canadian Investment Industry spans several decades and includes progressively senior roles with Merrill Lynch Canada culminating in the role of Managing Director of the Private Client division before it was acquired by Wood Gundy.  In this role he was responsible for all Merrill Lynch Canada branches.  Upon the successful completion of this acquisition, Mr. de Werth became the Chairman & CEO of CIBC Wood Gundy Private Client Investments Inc., in charge of the combined Private Client operation.  He was a member of both the Management Committee and the Executive Committee at CIBC Wood Gundy.  Mr. de Werth has served as a Director/Officer of several public and private companies including Chairman of hyperWALLET Systems Inc., Chairman of Rattlesnake Ventures and Director at Minsud Resources Corp.  He has also acted in a legal advisory capacity for several law firms in individual investor matters.

“I’m excited to be part of the Reliq Health team, working towards a common goal of making healthcare more accessible and affordable,” said Mr. Tony de Werth.  “I look forward to working with this passionate team to make a real contribution to the future of healthcare.”

Reliq’s iUGO Care digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and encouraging and tracking medication adherence. iUGO Care’s unique interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities.  iUGO Care’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions.  Reliq’s iUGO Care cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs, preventing costly and disruptive hospital readmissions and ER visits.




“Dr. Lisa Crossley”

CEO and Director


For further information contact:


Renmark Financial Communications Inc.

Laura Welsh:

Tel: (416) 644-2020 or (514) 939-3989


or CORE Capital Partners at 604-566-9233 or


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.


We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.


Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.


Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.


SOURCE: Reliq Health Technologies Inc.